Poolbeg Pharma (LON:POLB) Trading Down 0.7% – Should You Sell?

by · The Markets Daily

Poolbeg Pharma PLC (LON:POLB – Get Free Report) was down 0.7% during mid-day trading on Wednesday . The company traded as low as GBX 7.10 ($0.09) and last traded at GBX 7.10 ($0.09). Approximately 392,788 shares changed hands during mid-day trading, a decline of 76% from the average daily volume of 1,611,117 shares. The stock had previously closed at GBX 7.15 ($0.09).

Analyst Upgrades and Downgrades

Separately, Shore Capital reissued a “house stock” rating on shares of Poolbeg Pharma in a research note on Thursday.

View Our Latest Report on POLB

Poolbeg Pharma Trading Down 0.7 %

The firm has a 50-day moving average of GBX 7.58 and a 200 day moving average of GBX 10.02. The company has a market cap of £21.20 million, a P/E ratio of -424.00 and a beta of 2.11.

Poolbeg Pharma Company Profile

(Get Free Report)

Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.

Further Reading